Circadian Variation of Stroke Onset and Other Clinical Characteristics: A Single-Center Study

Similar documents
The Impact of Smoking on Acute Ischemic Stroke

CVD Prevention, Who to Consider

Clinical Features and Subtypes of Ischemic Stroke Associated with Peripheral Arterial Disease

JMSCR Vol 3 Issue 12 Page December 2015

Andrew Cohen, MD and Neil S. Skolnik, MD INTRODUCTION

Soo LIM, MD, PHD Internal Medicine Seoul National University Bundang Hospital

Statin therapy in patients with Mild to Moderate Coronary Stenosis by 64-slice Multidetector Coronary Computed Tomography

Statin Prescription Adhered to Guidelines for Patients Hospitalized due to Acute Ischemic Stroke or Transient Ischemic Attack

Session : Why do stroke patients need a cardiologist? PREVALENCE OF CORONARY ATHEROSCLEROSIS IN PATIENTS WITH CEREBRAL INFARCTION

CARDIOVASCULAR RISK FACTORS & TARGET ORGAN DAMAGE IN GREEK HYPERTENSIVES

The randomized study of efficiency and safety of antithrombotic therapy in

Hyperuricemia as a Prognostic Marker in Acute Ischemic Stroke

Clinical Features of Patients Who Come to Hospital at the Super Acute Phase of Stroke

Case Presentation. Rafael Bitzur The Bert W Strassburger Lipid Center Sheba Medical Center Tel Hashomer

High Levels of Apolipoprotein B/AI Ratio Are Associated With Intracranial Atherosclerotic Stenosis

The Framingham Coronary Heart Disease Risk Score

Thrombolysis in ischaemic stroke in rural North East Thailand by neurologist and non-neurologists

SUPPLEMENTAL MATERIAL

STATINS FOR PAD Long - term prognosis

Supplementary Online Content

There are many ways to lower triglycerides in humans: Which are the most relevant for pancreatitis and for CV risk?

HIGH LDL CHOLESTEROL IS NOT AN INDEPENDENT RISK FACTOR FOR HEART ATTACKS AND STROKES

Stroke Statistics in Korea: Part I. Epidemiology and Risk Factors: A Report from the Korean Stroke Society and Clinical Research Center for Stroke

Felix Vallotton Ball (1899) LDL-C management in Asian diabetes: moderate vs. high intensity statin --- a lesson from EMPATHY study

Non-commercial use only

Risk Factors for Ischemic Stroke: Electrocardiographic Findings

A: Epidemiology update. Evidence that LDL-C and CRP identify different high-risk groups

Module 2. Global Cardiovascular Risk Assessment and Reduction in Women with Hypertension

Serum levels of galectin-1, galectin-3, and galectin-9 are associated with large artery atherosclerotic

Redgrave JN, Coutts SB, Schulz UG et al. Systematic review of associations between the presence of acute ischemic lesions on

Review of guidelines for management of dyslipidemia in diabetic patients

Low-density lipoprotein as the key factor in atherogenesis too high, too long, or both

A Survey about the Temporal Pattern of Stroke Occurrence

Figure S1. Comparison of fasting plasma lipoprotein levels between males (n=108) and females (n=130). Box plots represent the quartiles distribution

The triglyceride:high-density lipoprotein-cholesterol ratio and steno-occlusive disease in the intracranial arteries

The JUPITER trial: What does it tell us? Alice Y.Y. Cheng, MD, FRCPC January 24, 2009

GENDER DISTRIBUTION OF RISK FACTORS IN ISCHEMIC STROKE IN HOSPITAL OF PSYCHIATRY AND NEUROLOGY FROM BRAŞOV

Effect of Medicine Adherence on the Occurrence of Cerebrovascular Disorders in Diabetes Mellitus Patients

Stroke Update. Lacunar 19% Thromboembolic 6% SAH 13% ICH 13% Unknown 32% Hemorrhagic 26% Ischemic 71% Other 3% Cardioembolic 14%

. Non HDL-c : Downloaded from ijdld.tums.ac.ir at 18:05 IRDT on Friday March 22nd Non HDL LDL. . LDL Non HDL-c

Supplementary webappendix

Stroke subtypes and risk factors of ischemic stroke in young Korean adults

Disclosures. State of the Art Management of Carotid Stenosis. NIH funding for clinical trials Consultant for Scientia Vascular and Medtronic

The incidence of transient myocardial ischemia,

Blood Pressure Variability and Hemorrhagic Transformation after Intravenous Thrombolysis in Acute Ischemic Stroke

A study to find out relationship in between serum uric acid level and stroke

CVD risk assessment using risk scores in primary and secondary prevention

The Epidemiology of Stroke and Vascular Risk Factors in Cognitive Aging

Slide 1. Slide 2 Conflict of Interest Disclosure. Slide 3 Stroke Facts. The Treatment of Intracranial Stenosis. Disclosure

Antithrombotic therapy in patients with transient ischemic attack / stroke (acute phase <48h)

Optimizing risk assessment of total cardiovascular risk What are the tools? Lars Rydén Professor Karolinska Institutet Stockholm, Sweden

Behind LDL: The Metabolism of ApoB, the Essential Apolipoprotein in LDL and VLDL

Cardiometabolics in Children or Lipidology for Kids. Stanley J Goldberg MD Diplomate: American Board of Clinical Lipidology Tucson, Az

03/30/2016 DISCLOSURES TO OPERATE OR NOT THAT IS THE QUESTION CAROTID INTERVENTION IS INDICATED FOR ASYMPTOMATIC CAROTID OCCLUSIVE DISEASE

Supplementary Online Content. Abed HS, Wittert GA, Leong DP, et al. Effect of weight reduction and

The Effect of Statin Therapy on Risk of Intracranial Hemorrhage

Min Hur, Eun-Hee Kim, In-Kyung Song, Ji-Hyun Lee, Hee-Soo Kim, and Jin Tae Kim INTRODUCTION. Clinical Research

NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE General practice Indicators for the NICE menu

ANTIHYPERTENSIVE DRUG THERAPY IN CONSIDERATION OF CIRCADIAN BLOOD PRESSURE VARIATION*

Management of LDL as a Risk Factor. Raul D. Santos MD, PhD Heart Institute-InCor University of Sao Paulo Brazil

Slide notes: References:

2013 Hypertension Measure Group Patient Visit Form

ISSN X (Print) Original Research Article. *Corresponding author Vaibhav. V. Biyani

The Japan Statin Treatment Against Recurrent Stroke (J-STARS): a multicenter, randomized, open-label, parallel-group study

Circadian patterns of ischemic stroke onset

APPENDIX B: LIST OF THE SELECTED SECONDARY STUDIES

Ischemic Heart and Cerebrovascular Disease. Harold E. Lebovitz, MD, FACE Kathmandu November 2010

ESPEN Congress Florence 2008

Guidelines on cardiovascular risk assessment and management

Life Science Journal 2018;15(12)

Neurological Features and Mechanisms of Acute Bilateral Cerebellar Infarction

CHAPTER 5. Symptomatic and Asymptomatic Retinal Embolism Have Different Mechanisms

Statistical Fact Sheet Populations

Lipoprotein (a) Disclosures 2/20/2013. Lipoprotein (a): Should We Measure? Should We Treat? Health Diagnostic Laboratory, Inc. No other disclosures

A study on risk factors and lipid profile pattern in patients of stroke in Osmania General Hospital, Hyderabad, India

JUPITER NEJM Poll. Panel Discussion: Literature that Should Have an Impact on our Practice: The JUPITER Study

Biomed Environ Sci, 2016; 29(3): LI Jian Hong, WANG Li Min, LI Yi Chong, ZHANG Mei, and WANG Lin Hong #

SCIENTIFIC STUDY REPORT

Thai people. Large epidemiology studies in ischemic stroke have shown a modest association of elevated total

Fasting Plasma Glucose and Risk of Incident Ischemic Stroke or Transient Ischemic Attacks. A Prospective Cohort Study

Preventing Myocardial Infarction in the Young Adult in the First Place: How Do the National Cholesterol Education Panel III Guidelines Perform?

Risk Assessment of developing type 2 diabetes mellitus in patient on antihypertensive medication

Women and Heart Disease

Luisa Vinciguerra. Ictus recidivanti

Epidemiologic and clinical comparison of renal artery stenosis in black patients and white patients

Safety of Anacetrapib in Patients with or

It is accepted by a broad consensus that a blood pressure

AGING, BLOOD PRESSURE & CARDIOVASCULAR DISEASE EVENT RISK. Michael Smolensky, Ph.D. The University of Texas Austin & Houston

ISSN: X Impact factor: 4.295

2010 Korean Society of Cardiology Spring Scientific Session Korea Japan Joint Symposium. Seoul National University Hospital Cardiovascular Center

Diabetes Mellitus: A Cardiovascular Disease

Journal of the American College of Cardiology Vol. 48, No. 2, by the American College of Cardiology Foundation ISSN /06/$32.

American Medical Women s Association Position Paper on Principals of Women & Coronary Heart Disease

9/18/2017 DISCLOSURES. Consultant: RubiconMD. Research: Amgen, NHLBI OUTLINE OBJECTIVES. Review current CV risk assessment tools.

Subtyping of Ischemic Stroke Based on Vascular Imaging: Analysis of 1,167 Acute, Consecutive Patients

Risk Factors for Heart Disease

How would you manage Ms. Gold

A trial fibrillation (AF) is a common arrhythmia that is

Risk Stratification of ACS Patients. Frans Van de Werf, MD, PhD University of Leuven, Belgium

Transcription:

ORIGINAL ARTICLE J Korean Sleep Res Soc 2014;11(2):61-65 pissn 1738-608X / eissn 2288-4912 http://dx.doi.org/10.13078/jksrs.14011 Circadian Variation of Stroke Onset and Other Clinical Characteristics: A Single-Center Study Yong Seo Koo 1, Sungwook Yu 1, Kyung-Hee Cho 1, Ki-Young Jung 2 1 Department of Neurology, Korea University Medical Center, Korea University College of Medicine, Seoul, 2 Department of Neurology, Seoul National University College of Medicine, Seoul, Korea Received December 11, 2014 Revised December 17, 2014 Accepted December 23, 2014 Address for correspondence Sungwook Yu, MD, PhD Department of Neurology, Korea University Medical Center, Korea University College of Medicine, 73 Inchon-ro, Seongbuk-gu, Seoul 136-705, Korea Tel: +82-2-920-6648 Fax: +82-2-925-2472 E-mail: song4yu@korea.ac.kr Objectives: This study was performed in order to delineate whether the onset of symptom onset follows circadian rhythm and to identify potential clinical characteristics with similar circadian distribution as that of symptom onset time in stroke patients. Methods: We retrospectively analyzed the data of subjects who were registered in a prospectively collected stroke registry in Korea University Medical Center Anam Hospital from September 2007 to December 2013. A Cosinor analysis was used to examine the circadian variation of the symptom onset of stroke as well as various clinical parameters. Results: A total of 2,047 patients with stroke were analyzed in our study. The Cosinor analysis showed significant circadian rhythm of stroke occurrence existed according to the symptom onset time of stroke (p<0.001) and the peak time for stroke occurrence was 12:22 (95% confidence interval 11:29 17:41). Cosinor analyses of other variables also showed significant circadian variation of age, fasting glucose, high-density lipoprotein (HDL), and lowdensity lipoprotein. The circadian distribution of low HDL was similar to that of stroke occurrence. Conclusions: The prevalence of stroke occurrence and low level of HDL peaked during the morning. J Korean Sleep Res Soc 2014;11(2):61-65 Key Words: Circadian rhythm, Stroke, High-density lipoprotein. Introduction Cardiovascular events tend to occur mostly in the morning. 1-3 Stroke is also known to occur most frequently in the morning. 4 Although previous studies speculated that circadian rhythm of blood pressure could affect the occurrence of stroke, a recent study showed that there is no significant circadian variation of blood pressure in stroke patients. 5 Furthermore, circadian variation of these clinical characteristics in stroke patients might affect prognosis after using tissue plasminogen activator. 6 Therefore, the knowledge of circadian variation of various clinical characteristics might help in understanding these differences in prognosis among stroke patients. However, circadian variability in stroke occurrence has not been properly evaluated in Korean stroke patients and there is no systematic studies regarding the circadian variation of clinical characteristics in stroke patients. Therefore, we tried to delineate whether the time of symptom onset in stroke patients follows circadian rhythm using Cosinor This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. analysis and to identify clinical characteristics which show similar circadian distribution as that of symptom onset time in stroke patients. Methods Subjects We retrospectively analyzed the data of subjects who were registered in a prospectively collected stroke registry in Korea University Medical Center Anam Hospital from September 2007 to December 2013. The stroke registry included patients with any kinds of stroke, mostly ischemic stroke, including transient ischemic attack (TIA) who were admitted to the department of neurology at our hospital. For this study, we included only adult patients with age of 18 years old or more at the time of stroke onset. We excluded those patients who did not have any information recorded about the symptom onset of stroke. Clinical variables Demographic variables such as age, gender, weight, height, body mass index (BMI), abdominal circumference were in- Copyright 2014 Korean Sleep Research Society 61

Circadian Variation of Stroke cluded. Systolic and diastolic blood pressures were measured at the time of admission. The etiologies of ischemic stroke were determined according to the Trial of Org 10172 in Acute Stroke Treatment classification: large-artery atherosclerosis (LAA), cardioembolism (CE), small-vessel occlusion (SVO), stroke of other determined etiology (OTHER), and stroke of undetermined etiology (UNDETERMINED). 7 Laboratory data such as fasting glucose, hemoglobin A1c, total cholesterol, high-density lipoprotein (HDL), low-density lipoprotein (LDL), triglyceride (TG), and lipoprotein(a) [Lp(a)] were obtained at fasting state in the morning. The symptom onset time was recorded at the registry. The situation at the symptom onset time in stroke patients were classified as 1) during sleep, 2) upon awakening, 3) during normal daily activity, and 4) unknown. Even if the stroke occurred during sleep or the time of symptom onset was not clear, we tried to estimate the time of stroke using the last normal time. When there was no informant who could give us the information about the symptom onset time of stroke, we recorded the date of symptom onset as the first abnormal time and the time as 00:00. When the symptom onset time of stroke was known, we recorded the symptom onset time up to minutes. Statistical analyses A Cosinor analysis was used to examine the circadian variation of the symptom onset of stroke as well as various clinical parameters with the model specified as below: 8 f(t)=m+a cos( 2πt p -Ф) where f(t) is a value which we selected to know its circadian rhythmicity, M is the mesor, A is the amplitude, P is the period (in our case, 24 hours), t is the time, and Ф is the acrophase. At first, we analyzed whether the number of patients varies according to circadian rhythm. Then, we analyzed the circadian rhythm of age, weight, height, abdominal circumference, BMI, fasting glucose, hemoglobin A1c, total cholesterol, HDL, LDL, TG, and Lp(a) according to the onset time of stroke. For the variables with similar distribution, Pearson s correlation analysis was performed. Statistical analysis was performed using R 3.0.3. Results Patient characteristics 2,588 patients with stroke were included in this study. The onset time of stroke in 179 patients were not recorded. Although the onset of stroke occurred during sleep in 122 patients and was unclear in 293 patients, we tried to estimate the onset time of stroke using the last normal time. Therefore, we only excluded 362 patients whose symptom onset was exactly at 00:00, since the time of 00:00 was the default time of the symptom onset time for our Stroke Registry program. Among the excluded patients, 13 patients had stroke during sleep and 107 patients had unclear onset. Finally, a total of 2,047 patients with stroke were analyzed in our study. Mean age at stroke onset was 66.9±12.6 years and 61% of the patients were men (Table 1). Symptom onset time in stroke patients Stroke occurred most frequently at times of 06:00 12:00 and least frequently at times of 00:00 06:00. Fig. 1A shows the histogram of the symptom onset time. This was also confirmed by Cosinor analysis (Fig. 1B). The Cosinor analysis Table 1. Clinical characteristics of stroke patients No. of patients 2,047 Age, years 66.9±12.6 Men, % 1,243 (61) Weight, kg 63.1±11.4 Height, cm 160.4±13.6 Abdominal circumference, cm 85.1±10.9 Body mass index, kg/m 2 25.1±17.3 Systolic blood pressure, mm Hg 150.0±44.3 Diastolic blood pressure, mm Hg 87.6±14.6 Etiology of stroke TIA 198 (10%) SVO 398 (21%) LAA 551 (29%) CE 412 (22%) OTHER 33 (2%) UNDETERMINED 324 (17%) Symptom onset time of stroke 00:00 06:00 189 (9%) 06:00 12:00 664 (32%) 12:00 18:00 661 (32%) 18:00 00:00 533 (26%) Fasting glucose, mg/dl 130.0±60.9 Hemoglobin A1c, % 6.6±1.7 Total cholesterol, mg/dl 170.5±42.2 High-density lipoprotein, mg/dl 43.8±12.3 Low-density lipoprotein, mg/dl 95.6±29.4 Triglyceride, mg/dl 131.9±89.7 Lipoprotein(a), mg/dl 25.0±24.7 TIA: transient ischemic attack, SVO: small-vessel occlusion, LAA: large-artery atherosclerosis, CE: cardioembolism, OTHER: stroke of other determined etiology, UNDETERMINED: stroke of undetermined etiology 62

Koo YS et al. showed significant circadian rhythm of stroke occurrence existed according to the symptom onset time of stroke (p<0.001) and the peak time for stroke occurrence was 12:22 [95% confidence interval (CI) 11:29 17:41]. Other subgroups according to gender (men and women) and stroke types (TIA, SVO, LAA, CE, OTHER, and UNDETERMINED) all showed significant circadian rhythms with similar distributions. Circadian variations of other clinical variables Cosinor analyses of other variables also showed significant circadian variation of age, fasting glucose, HDL, and LDL. The Cosinor analysis showed significant circadian rhythm of age existed according to the symptom onset time of stroke (p=0.036) and the time for the oldest age was 14:52 (95% CI 11:54 18:58) (Fig. 2A). Since age showed circadian variation according stroke onset time, we analyzed the circadian variation of stroke occurrence in older ( 67 years old) and younger (<67 years old) patients. In older patients, the Cosinor analysis showed significant circadian rhythm of stroke occurrence existed according to the symptom onset time of stroke (p< 0.001) and the peak time for stroke occurrence was 12:27 (95% CI 11:23 13:32). In younger patients, the Cosinor analysis showed significant circadian rhythm of stroke occurrence existed according to the symptom onset time of stroke (p<0.001) and the peak time for stroke occurrence was 11:34 (95% CI 10:38 14:38). The Cosinor analysis showed significant circadian rhythm of fasting glucose existed according to the symptom onset time of stroke (p=0.019) and the time for the highest fasting glucose was 20:43 (95% CI 16:30 04:29) (Fig. 2B). The Cosinor analysis showed significant circadian rhythm of HDL existed according to the symptom onset time of stroke (p= 0.007) and the time for the lowest HDL was 13:49 (95% CI 11:10 19:21) (Fig. 2C). The Cosinor analysis showed significant circadian rhythm of LDL existed according to the symptom onset time of stroke (p=0.040) and the time for the highest LDL was 02:42 (95% CI 23:43 16:22) (Fig. 2D). Other clinical variables did not show significant circadian variation according to the symptom onset time of stroke. Weight (p=0.260), height (p=0.750), abdominal circumference (p=0.123), BMI (p=0.299), systoilic/diastolic blood pressures (p=0.086 and 0.220), hemoglobin A1c (p=0.739), total cholesterol (p=0.057), TG (p=0.071), and Lp(a) (p=0.163) did not have significant circadian variation Number of patients 200 150 100 50 5.0 4.5 4.0 3.5 3.0 A 0 0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 2.5 Figure 1. Distribution of symptom onset time in stroke patients. This shows the distribution of stroke patients according to the symptom onset time. (A) The histogram of the symptom onset time shows highest prevalence of stroke onset during early morning. (B) The Cosinor analysis showed significant circadian rhythm of the symptom onset time of stroke (p<0.001) and the peak time for stroke occurrence was 12:22 (95% confidence interval 11:29 17:41). B 67.5 67.0 66.5 66.0 A B 134 132 130 128 45.0 44.5 44.0 43.5 43.0 C 98 97 96 95 94 D Figure 2. Cosinor plot of symptom onset. Cosinor analyses of other variables also showed significant circadian variation of (A) age, (B) fasting glucose, (C) high-density lipoprotein, and (D) low-density lipoprotein. See details in the manuscript. http://journal.sleepnet.or.kr 63

Circadian Variation of Stroke according the symptom onset time in stroke patients. Discussion In this study, we analyzed circadian rhythm of stroke onset as well as that of various clinical factors in stroke patients. The symptom onset time of stroke occurrence showed significant circadian rhythm with peak time of 12:22. Furthermore, age, fasting glucose, HDL, and LDL also showed significant circadian rhythms. Our study replicated previous studies in that stroke occurred most frequently during the time of 06:00 12:00. 4,9-11 For example, a meta-analysis concluded that there is a circadian rhythm in the onset of stroke, that is, increased risk of the onset of acute stroke during the early morning hours. 4 This meta-analysis concluded that this finding occurs across the various subtypes of stroke such as ischemic stroke, hemorrhagic stroke, and TIA. We also included all types of the stroke, although most of the stroke was ischemic stroke. This circadian rhythm has also been confirmed by other study with large population up to 1,395 patients. 12 It showed significant circadian variation and suggested that circadian variability of blood pressure might be associated with the risk of stroke. However, our result did not reveal the circadian variability of blood pressure. Cosinor analysis showed the peak time of stroke occurrence as 12:22, which is a little delayed compared to the previous studies. In our study, older patients had delayed stroke occurrence compared to younger patients. Therefore, the delayed occurrence of stroke in our study seems to result from older age of stroke patients in our study compared to the previous studies. 4,9-11 The reason for delayed stroke onset time in older stroke patients can be speculated that the disruption of circadian rhythm in elderly patients might play some role. For example, melatonin, which is a primary modulator of circadian rhythms in humans, is also a free radical scavenger and antioxidant and might have some role in neuroprotection for stroke patients. 13 In our study, the circadian variation of HDL according to stroke onset time was similar to the distribution of number of stroke patients according to the stroke onset time. Since the HDL is known to have protective role in stroke risk, 14-23 similar circadian variation of low HDL and stroke occurrence seems plausible. Since the level of HDL is known to be the lowest in the morning, 24 this might explain why patients with low HDL have stroke during the morning. However, the causal relationship between HDL and stroke occurrence cannot be determined in our retrospective study. On the other hand, our study found no circadian variation in the blood pressure as the previous study has noted. 5 Although fasting glucose (highest during the evening) and LDL (highest during the dawn) showed significant circadian variation, they do not seem to be related to stroke occurrence. Previous researchers have suggested several implications on circadian rhythm regarding stroke onset. For example, there were false notion in the past that most strokes occur during sleep, 4 which is shown not to be true in the previous studies as well as ours. Since prevention is very important in stroke patients, some risk factors for stroke might be suggested using this kind of analysis. 4,12 The limitation of our study was retrospective design. We did not control all possible confounding factors. Our population does not represent a community-based population because our patients were recruited from only neurology department and a single-center hospital. We did not investigate stroke patients according to various stroke subtypes. However, previous study has shown that there were no differences of stroke occurrence according to different subtypes. The population also included recurrent strokes. REFERENCES 1. Muller JE, Stone PH, Turi ZG, et al. Circadian variation in the frequency of onset of acute myocardial infarction. N Engl J Med 1985; 313:1315-1322. 2. Willich SN, Levy D, Rocco MB, Tofler GH, Stone PH, Muller JE. Circadian variation in the incidence of sudden cardiac death in the Framingham Heart Study population. Am J Cardiol 1987;60:801-806. 3. Mulcahy D, Keegan J, Cunningham D, et al. Circadian variation of total ischaemic burden and its alteration with anti-anginal agents. Lancet 1988; 2:755-759. 4. Elliott WJ. Circadian variation in the timing of stroke onset: a metaanalysis. Stroke 1998;29:992-996. 5. Zhang W, Cadilhac DA, Churilov L, Donnan GA, O Callaghan C, Dewey HM. Does abnormal circadian blood pressure pattern really matter in patients with transient ischemic attack or minor stroke? Stroke 2014; 45:865-867. 6. Vilas D, Gomis M, Blanco M, et al. Circadian rhythms in the efficacy of intravenous alteplase in patients with acute ischemic stroke and middle cerebral artery occlusion. Chronobiol Int 2012;29:1383-1389. 7. Adams HP Jr, Bendixen BH, Kappelle LJ, et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke 1993; 24:35-41. 8. Tong YL. Parameter estimation in studying circadian rhythms. Biometrics 1976;32:85-94. 9. Tsementzis SA, Gill JS, Hitchcock ER, Gill SK, Beevers DG. Diurnal variation of and activity during the onset of stroke. Neurosurgery 1985; 17:901-904. 10. Marler JR, Price TR, Clark GL, et al. Morning increase in onset of ischemic stroke. Stroke 1989;20:473-476. 11. Turin TC, Kita Y, Rumana N, et al. Morning surge in circadian periodicity of ischaemic stroke is independent of conventional risk factor status: findings from the Takashima Stroke Registry 1990-2003. Eur J Neurol 2009;16:843-851. 12. Casetta I, Granieri E, Fallica E, la Cecilia O, Paolino E, Manfredini R. Patient demographic and clinical features and circadian variation in onset of ischemic stroke. Arch Neurol 2002;59:48-53. 13. Shinozuka K, Staples M, Borlongan CV. Melatonin-based therapeutics 64

Koo YS et al. for neuroprotection in stroke. Int J Mol Sci 2013;14:8924-8947. 14. Tirschwell DL, Smith NL, Heckbert SR, Lemaitre RN, Longstreth WT Jr, Psaty BM. Association of cholesterol with stroke risk varies in stroke subtypes and patient subgroups. Neurology 2004;63:1868-1875. 15. Soyama Y, Miura K, Morikawa Y, et al. High-density lipoprotein cholesterol and risk of stroke in Japanese men and women: the Oyabe Study. Stroke 2003;34:863-868. 16. Walldius G, Aastveit AH, Jungner I. Stroke mortality and the apob/ apoa-i ratio: results of the AMORIS prospective study. J Intern Med 2006;259:259-266. 17. Koren-Morag N, Tanne D, Graff E, Goldbourt U. Low- and high-density lipoprotein cholesterol and ischemic cerebrovascular disease: the bezafibrate infarction prevention registry. Arch Intern Med 2002;162: 993-999. 18. Wannamethee SG, Shaper AG, Ebrahim S. HDL-Cholesterol, total cholesterol, and the risk of stroke in middle-aged British men. Stroke 2000;31:1882-1888. 19. Lindenstrøm E, Boysen G, Nyboe J. Influence of total cholesterol, high density lipoprotein cholesterol, and triglycerides on risk of cerebrovascular disease: the Copenhagen City Heart Study. BMJ 1994;309:11-15. 20. Tanne D, Yaari S, Goldbourt U. High-density lipoprotein cholesterol and risk of ischemic stroke mortality. A 21-year follow-up of 8586 men from the Israeli Ischemic Heart Disease Study. Stroke 1997;28:83-87. 21. Sacco RL, Benson RT, Kargman DE, et al. High-density lipoprotein cholesterol and ischemic stroke in the elderly: the Northern Manhattan Stroke Study. JAMA 2001;285:2729-2735. 22. Simons LA, Simons J, Friedlander Y, McCallum J. Cholesterol and other lipids predict coronary heart disease and ischaemic stroke in the elderly, but only in those below 70 years. Atherosclerosis 2001;159:201-208. 23. Milionis HJ, Liberopoulos E, Goudevenos J, Bairaktari ET, Seferiadis K, Elisaf MS. Risk factors for first-ever acute ischemic non-embolic stroke in elderly individuals. Int J Cardiol 2005;99:269-275. 24. Rivera-Coll A, Fuentes-Arderiu X, Díez-Noguera A. Circadian rhythmic variations in serum concentrations of clinically important lipids. Clin Chem 1994;40:1549-1553. http://journal.sleepnet.or.kr 65